Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.42 USD | +2.07% | +15.07% | +19.91% |
Apr. 16 | Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup | DJ |
Apr. 16 | ProPhase Labs, Inc. Unveils Project ZenQ-AI | CI |
Financials (USD)
Sales 2024 * | 54.79M | Sales 2025 * | 138M | Capitalization | 95.82M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | 11M | EV / Sales 2024 * | 1.75 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.69 x |
P/E ratio 2024 * |
-6.57
x | P/E ratio 2025 * |
11.3
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.03% |
Latest transcript on ProPhase Labs, Inc.
1 day | +2.07% | ||
1 week | +15.07% | ||
Current month | +17.57% | ||
1 month | -18.13% | ||
3 months | +6.69% | ||
6 months | +19.38% | ||
Current year | +19.91% |
Managers | Title | Age | Since |
---|---|---|---|
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Chief Operating Officer | 50 | Dec. 31 | |
Robert Morse
AUD | Comptroller/Controller/Auditor | 49 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Gleckel
BRD | Director/Board Member | 68 | 09-05-31 |
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Jason Barr
BRD | Director/Board Member | 44 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 27 M€ | -4.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 5.42 | +2.07% | 38,407 |
24-05-02 | 5.31 | +2.31% | 44,554 |
24-05-01 | 5.19 | +12.58% | 31,942 |
24-04-30 | 4.61 | 0.00% | 54,489 |
24-04-29 | 4.61 | -2.12% | 22,056 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.91% | 95.82M | |
-18.58% | 8.15B | |
+47.25% | 3.82B | |
-8.58% | 2.47B | |
-38.71% | 2.46B | |
-10.06% | 2.34B | |
-5.44% | 1.88B | |
-17.79% | 1.55B | |
-40.78% | 1.21B | |
+6.69% | 1.11B |
- Stock Market
- Equities
- PRPH Stock